“Welcome to the Humiraverse”

from DavidHealy.org
August 15, 2013

Editorial Note: This post in the AbbVie series is by Johanna Ryan from the RxISK Community Advisory Board
“You might think that Cynthia DiBartolo had an airtight case – unless you know about a feature of American law called the Learned Intermediary Doctrine. This doctrine, accepted in most U.S. courts, holds that in most circumstances a drugmaker has no duty to warn the patient directly of possible adverse effects.”

Worth the read-a numbly unsurprising verse but watch how that plays out.

from wikipedia:
“Learned intermediary is a defense doctrine used in the legal system of the United States. This doctrine states that a manufacturer of a product has fulfilled his duty of care when he provides all of the necessary information to a “learned intermediary” who then interacts with the consumer of a product. This doctrine is primarily used by pharmaceutical and medical device manufacturers in defense of tort suits.

In a clear majority of states, the courts have accepted this as a liability shield for pharmaceutical companies.”

This would also strain patient/doc interaction because of liability. No one really wins. All this could be absolutely different by rethinking the “gold” standard clinical trials:

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s